Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202300670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Ahammed A Thottasseri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Pondicherry University, Puducherry, India. Hauptthemen laut MEDLINE: Influenza A virus, Clathrin, Antiviral Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: University Grants Commission (UGC), New Delhi.
Abstract (Originalsprache)
Influenza A virus (IAV) is a highly contagious respiratory pathogen that significantly threatens global health by causing seasonal epidemics and occasional, unpredictable pandemics. To identify new compounds with therapeutic potential against IAV, we designed and synthesized a series of 4′‐morpholinodiazenyl chalcones using the molecular hybridization method, performed a high‐content screen against IAV, and found that ( E )‐1‐{4‐[( E )‐morpholinodiazenyl]phenyl}‐3‐(3,4,5‐trimethoxyphenyl)prop‐2‐en‐1‐one (MC‐22) completely neutralized IAV infection. While MC‐22 allowed IAV to successfully internalize into the cell and fuse at the acidic late endosomes, it prevented viral capsid uncoating and genome release. Since IAV majorly utilizes clathrin‐mediated endocytosis (CME) for cellular entry, we examined whether MC‐22 had any effect on CME, using nonviral cargoes that enter cells via clathrin‐dependent or ‐independent pathways. Although MC‐22 showed no effect on the uptake of choleratoxin B, a cargo that enters cells majorly via the clathrin‐independent pathway, it significantly attenuated the clathrin‐dependent internalization of both epidermal growth factor and transferrin. Cell biological analyses revealed a marked increase in the size of early endosomes upon MC‐22 treatment, indicating an endosomal trafficking/maturation defect. This study reports the identification of MC‐22 as a novel CME‐targeting, highly potent IAV entry inhibitor, which is expected to neutralize a broad spectrum of viruses that enter the host cells via CME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Pondicherry University, Puducherry, India.
- Cellular Virology Lab, Department of Biological Sciences, Indian Institute of Science Education and Research, Mohali (IISER Mohali), Mohali, India.
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.
Förderung
- University Grants Commission (UGC), New Delhi
Zitieren
APA
Thottasseri, A. A., Kaur, G., Ramesh, D., Banerjee, I., & Kannan, T. (2024). Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300670
Vancouver
Thottasseri AA, Kaur G, Ramesh D, Banerjee I, Kannan T. Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300670
BibTeX
@article{Thottasseri2024,
author = {Thottasseri, Ahammed A and Kaur, Gaganpreet and Ramesh, Deepthi and Banerjee, Indranil and Kannan, Tharanikkarasu},
title = {Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202300670}
}
EUVIMED